• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

按癌症部位进行的基因检测:卵巢。

Genetic testing by cancer site: ovary.

机构信息

NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL 60201, USA.

出版信息

Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.

DOI:10.1097/PPO.0b013e31826246c2
PMID:22846732
Abstract

Approximately 1 in every 4 to 5 women with a diagnosis of ovarian cancer has a hereditary gene mutation that is responsible for the development of her cancer. Identifying women at increased risk of developing ovarian cancer due to a hereditary cancer syndrome can allow for early detection or prevention of not only ovarian cancer, but also other cancers, depending on the causative gene. This review focuses on 3 of the most common hereditary ovarian cancer syndromes, hereditary breast and ovarian cancer syndrome (the BRCA1 and BRCA2 genes), Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer syndrome), and Peutz-Jeghers syndrome, including key features, genetics, and management of these syndromes. In addition, newly discovered genes (eg, RAD51C and RAD51D) linked to ovarian cancer are discussed.

摘要

约每 4 至 5 位被诊断出卵巢癌的女性中,就有 1 位存在导致其癌症发生的遗传性基因突变。由于遗传性癌症综合征,女性患卵巢癌的风险增加,可以通过早期检测或预防不仅是卵巢癌,而且还可以预防其他癌症,具体取决于致病基因。这篇综述主要集中在 3 种最常见的遗传性卵巢癌综合征,遗传性乳腺癌和卵巢癌综合征(BRCA1 和 BRCA2 基因)、林奇综合征(也称为遗传性非息肉病性结直肠癌综合征)和 Peutz-Jeghers 综合征,包括这些综合征的关键特征、遗传学和管理。此外,还讨论了与卵巢癌相关的新发现基因(如 RAD51C 和 RAD51D)。

相似文献

1
Genetic testing by cancer site: ovary.按癌症部位进行的基因检测:卵巢。
Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
2
Genetic testing by cancer site: pancreas.按癌症部位进行基因检测:胰腺。
Cancer J. 2012 Jul-Aug;18(4):350-4. doi: 10.1097/PPO.0b013e3182624694.
3
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.BRCA1/2 和 Lynch 综合征患者缺乏遗传咨询和检测转诊:基于 240134 次就诊和 134652 次基因检测的全国性研究。
Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24.
4
Genetic testing for cancer predisposition.癌症易感性的基因检测。
Annu Rev Med. 2001;52:371-400. doi: 10.1146/annurev.med.52.1.371.
5
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
6
Hereditary breast-ovarian cancer: clinical findings and medical management.遗传性乳腺癌-卵巢癌:临床发现与医学管理
Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. doi: 10.1097/01.PSN.0000290280.48197.e7.
7
[The pathology of hereditary ovarian tumors].[遗传性卵巢肿瘤的病理学]
Ann Pathol. 2020 Apr;40(2):85-94. doi: 10.1016/j.annpat.2020.02.015. Epub 2020 Mar 13.
8
Genetic testing by cancer site: stomach.按癌症部位进行的基因检测:胃部。
Cancer J. 2012 Jul-Aug;18(4):355-63. doi: 10.1097/PPO.0b013e31826246dc.
9
Genetics and ovarian carcinoma.遗传学与卵巢癌
Semin Oncol. 1998 Jun;25(3):265-80.
10
Clinical genetics of hereditary colorectal cancer.遗传性结直肠癌的临床遗传学。
Hematol Oncol Clin North Am. 2010 Oct;24(5):837-59. doi: 10.1016/j.hoc.2010.06.006.

引用本文的文献

1
Established Cancer Predisposition Genes in Single and Multiple Cancer Diagnoses.单发性和多发性癌症诊断中已确定的癌症易感基因。
JAMA Oncol. 2025 Aug 28. doi: 10.1001/jamaoncol.2025.2879.
2
Performance of Liquid Biopsy-Based Multi-Omics Biomarkers for Early Detection of Gynecological Malignancies: A Prospective Study (PERCEIVE-I).基于液体活检的多组学生物标志物用于妇科恶性肿瘤早期检测的性能:一项前瞻性研究(PERCEIVE-I)
Adv Sci (Weinh). 2025 May;12(20):e2401760. doi: 10.1002/advs.202401760. Epub 2025 Apr 3.
3
Self-reported awareness of genetic testing, the impact of family history, and access to clinical trials for people diagnosed with ovarian cancer in Australia.
澳大利亚卵巢癌确诊患者的基因检测自我报告知晓情况、家族史的影响及临床试验参与情况
Gynecol Oncol Rep. 2024 Jun 7;54:101427. doi: 10.1016/j.gore.2024.101427. eCollection 2024 Aug.
4
Modifiable risk factors in women at high risk of breast cancer: a systematic review.高乳腺癌风险女性的可改变风险因素:系统评价。
Breast Cancer Res. 2023 Apr 24;25(1):45. doi: 10.1186/s13058-023-01636-1.
5
Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy.遗传性卵巢癌:迈向具有成本效益的预防策略。
Int J Environ Res Public Health. 2022 Sep 23;19(19):12057. doi: 10.3390/ijerph191912057.
6
Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer.晚期卵巢癌病理完全缓解者的临床分析。
Gynecol Oncol. 2022 Apr;165(1):82-89. doi: 10.1016/j.ygyno.2022.02.006. Epub 2022 Feb 23.
7
Peutz-Jeghers syndrome: Skin manifestations and endocrine anomalies (Review).黑斑息肉综合征:皮肤表现与内分泌异常(综述)
Exp Ther Med. 2021 Dec;22(6):1387. doi: 10.3892/etm.2021.10823. Epub 2021 Sep 29.
8
Treatment algorithm in patients with ovarian cancer.卵巢癌患者的治疗算法
Facts Views Vis Obgyn. 2020 Oct 8;12(3):227-239.
9
Risks of Second Primary Gynecologic Cancers following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000-2016.美国亚裔亚群人群中卵巢癌治疗后的二次妇科癌症发病风险,2000-2016 年。
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2220-2229. doi: 10.1158/1055-9965.EPI-20-0095. Epub 2020 Aug 20.
10
Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.BRCA1/2 突变携带者癌症预防项目的成本效益
Rev Saude Publica. 2018 Nov 29;52:94. doi: 10.11606/S1518-8787.2018052000643.